NL300315I1 - Papillomavirus vaccins - Google Patents

Papillomavirus vaccins

Info

Publication number: NL300315I1
Authority: NL; Netherlands
Prior art keywords: antibodies; useful; papillomavirus vaccines; vaccines; mimics
Prior art date: 1992-06-25

Application number

NL300315C

Other languages

English (en)

Other versions

NL300315I2 (nl

Original Assignee

Univ Georgetown

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-25

Filing date

2007-12-14

Publication date

2008-02-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25416951&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300315(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-12-14 Application filed by Univ Georgetown filed Critical Univ Georgetown

2008-02-01 Publication of NL300315I1 publication Critical patent/NL300315I1/nl

2008-03-03 Publication of NL300315I2 publication Critical patent/NL300315I2/nl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Virology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NL300315C 1992-06-25 2007-12-14 Papillomavirus vaccines NL300315I2 (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US90310992A	1992-06-25	1992-06-25
PCT/US1993/006109 WO1994000152A1 (en)	1992-06-25	1993-06-24	Papillomavirus vaccines

Publications (2)

Publication Number	Publication Date
NL300315I1 true NL300315I1 (nl)	2008-02-01
NL300315I2 NL300315I2 (nl)	2008-03-03

Family

ID=25416951

Family Applications (8)

Application Number	Title	Priority Date	Filing Date
NL300320C NL300320I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300322C NL300322I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300318C NL300318I2 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300316C NL300316I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300319C NL300319I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300315C NL300315I2 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccines
NL300317C NL300317I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300321C NL300321I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins

Family Applications Before (5)

Application Number	Title	Priority Date	Filing Date
NL300320C NL300320I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300322C NL300322I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300318C NL300318I2 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300316C NL300316I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300319C NL300319I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
NL300317C NL300317I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins
NL300321C NL300321I1 (nl)	1992-06-25	2007-12-14	Papillomavirus vaccins

Country Status (12)

Country	Link
US (2)	US20020068326A1 (nl)
EP (2)	EP1835029A1 (nl)
AT (1)	ATE380871T1 (nl)
AU (1)	AU697743C (nl)
DE (9)	DE122007000100I1 (nl)
DK (1)	DK0647140T3 (nl)
ES (1)	ES2294778T3 (nl)
FR (1)	FR07C0073I2 (nl)
LU (8)	LU91395I2 (nl)
NL (8)	NL300320I1 (nl)
PT (1)	PT647140E (nl)
WO (1)	WO1994000152A1 (nl)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1471147A3 (en)	1991-07-19	2007-03-21	The University Of Queensland	Method of making a recombinant molecule for the expression of HPV-16 L1 protein
US5437951A (en) *	1992-09-03	1995-08-01	The United States Of America As Represented By The Department Of Health And Human Services	Self-assembling recombinant papillomavirus capsid proteins
US8062642B1 (en)	1993-03-09	2011-11-22	University Of Rochester	Production of papillomavirus capsid protein and virus-like particles
US6153201A (en) *	1993-03-09	2000-11-28	University Of Rochester	Oral immunization with papillomavirus virus-like particles
DE4415743C2 (de) *	1994-05-04	1996-10-10	Deutsches Krebsforsch	Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US5888516A (en) *	1994-05-16	1999-03-30	Merck & Co. Inc.	Recombinant papillomavirus vaccines
AU693203B2 (en) *	1994-05-16	1998-06-25	Merck Sharp & Dohme Corp.	Papillomavirus vaccines
AU683564B2 (en) *	1994-05-17	1997-11-13	University Of Queensland, The	Recombinant papilloma virus L1
AUPM566794A0 (en) *	1994-05-17	1994-06-09	University Of Queensland, The	Process and product
AU694269B2 (en) *	1994-09-22	1998-07-16	Merck Sharp & Dohme Corp.	Dna encoding human papillomavirus type 6a
PT809700E (pt)	1994-10-07	2006-09-29	Univ Loyola Chicago	Particulas semelhantes ao papilomavirus e proteinas de fusao, assim como metodos para a sua producao
US5820870A (en) *	1995-03-22	1998-10-13	Merck & Co., Inc.	Recombinant human papillomavirus type 18 vaccine
IL117459A (en) *	1995-03-22	2005-11-20	Merck & Co Inc	Dna encoding human papillomavirus type 18
US5840306A (en) *	1995-03-22	1998-11-24	Merck & Co., Inc.	DNA encoding human papillomavirus type 18
US6908615B1 (en)	1996-03-18	2005-06-21	Merck & Co., Inc.	DNA encoding human papilloma virus type 18
GB9621091D0 (en)	1996-10-09	1996-11-27	Fondation Pour Le Perfectionem	Attenuated microorganisms strains and their uses
CA2295316C (en) *	1997-07-03	2007-06-26	University Of Colorado, University Technology Corporation	Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture, and the use thereof as diagnostic, prophylactic or therapy
US6228368B1 (en)	1997-10-06	2001-05-08	Loyola University Of Chicago	Papilloma virus capsomere formulations and method of use
US7182947B2 (en)	1998-02-20	2007-02-27	Medigene Ag	Papillomavirus truncated L1 protein and fusion protein constructs
US7494658B2 (en)	1998-02-20	2009-02-24	Medigene Ag	Papilloma virus truncated L1 protein and fusion protein constructs
US20020039584A1 (en)	1998-02-20	2002-04-04	Medigene Ag	Papilloma virus capsomere vaccine formulations and methods of use
CA2229955C (en)	1998-02-20	2003-12-09	Medigene Gmbh	Papilloma virus capsomere vaccine formulations and methods of use
US6926897B1 (en)	1998-03-24	2005-08-09	Medigene Aktiengesellschaft	Medicament for the avoidance or treatment of papillomavirus-specific tumour
EP1104442A1 (en)	1998-07-13	2001-06-06	Loyola University Of Chicago	Papillomavirus cellular receptor
US6692752B1 (en)	1999-09-08	2004-02-17	Smithkline Beecham Biologicals S.A.	Methods of treating human females susceptible to HSV infection
CN100406060C (zh) *	1998-10-16	2008-07-30	史密丝克莱恩比彻姆生物有限公司	一种佐剂组合物
GB0109297D0 (en)	2001-04-12	2001-05-30	Glaxosmithkline Biolog Sa	Vaccine
CA2457804C (en)	2001-08-13	2012-10-16	University Of Rochester	Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
GB0206360D0 (en) *	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
EP1925626A1 (en)	2003-07-21	2008-05-28	Transgene S.A.	Novel multifunctional cytokines
TWI457133B (zh)	2005-12-13	2014-10-21	Glaxosmithkline Biolog Sa	新穎組合物
EP2484375B1 (en)	2006-09-26	2018-05-23	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
US20090181078A1 (en)	2006-09-26	2009-07-16	Infectious Disease Research Institute	Vaccine composition containing synthetic adjuvant
CN101675068A (zh)	2007-03-02	2010-03-17	葛兰素史密丝克莱恩生物有限公司	新的方法和组合物
CN106377767A (zh)	2008-05-26	2017-02-08	卡迪拉保健有限公司	麻疹‑人乳头瘤组合疫苗
GB0815872D0 (en)	2008-09-01	2008-10-08	Pasteur Institut	Novel method and compositions
GB0820822D0 (en)	2008-11-13	2008-12-24	Inst Catala D Oncologia	Novel product and processes
EP2414512A1 (en) *	2009-04-03	2012-02-08	Deutsches Krebsforschungszentrum	Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
RU2732574C2 (ru)	2009-06-05	2020-09-21	Инфекшес Дизиз Рисерч Инститьют	Синтетические глюкопиранозиллипидные адъюванты
WO2011026111A1 (en)	2009-08-31	2011-03-03	The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Oral delivery of a vaccine to the large intestine to induce mucosal immunity
CA2795403C (en)	2010-04-08	2019-01-15	University Of Pittsburgh-Of The Commonwealth System Of Higher Education	B-cell antigen presenting cell assay
MX350795B (es)	2011-04-08	2017-09-19	Inmune Design Corp	Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
CN110339160A (zh)	2012-02-07	2019-10-18	传染性疾病研究院	包含tlr4激动剂的改进佐剂制剂及其使用方法
DK2850431T3 (en)	2012-05-16	2018-07-16	Immune Design Corp	Vaccines against HSV-2
CN109134640A (zh)	2012-10-23	2019-01-04	爱默蕾大学	Gm-csf和il-4轭合物、组合物以及与其相关的方法
EA032326B1 (ru)	2013-04-18	2019-05-31	Иммьюн Дизайн Корп.	Монотерапия gla для применения в лечении рака
US9463198B2 (en)	2013-06-04	2016-10-11	Infectious Disease Research Institute	Compositions and methods for reducing or preventing metastasis
EP3089754B1 (en)	2013-12-31	2021-04-21	Infectious Disease Research Institute	Single vial vaccine formulations
BR112018017141A2 (pt)	2016-02-22	2019-01-02	Boehringer Ingelheim Vetmedica Gmbh	método para a imobilização de biomoléculas
KR102483033B1 (ko)	2016-05-16	2022-12-30	액세스 투 어드밴스드 헬스 인스티튜트	페길화된 리포솜 및 이의 용도
BR112018073690B1 (pt)	2016-05-16	2022-05-24	Infectious Disease Research Institute	Formulação contendo agonista de tlr e métodos de uso
MX393217B (es)	2016-06-01	2025-03-11	Infectious Disease Res Inst	Particulas de nanoalumbre que contienen un agente de dimensionamiento
EP3638207B1 (en)	2017-06-15	2024-12-18	Access to Advanced Health Institute	Nanostructured lipid carriers and stable emulsions and uses thereof
AU2018330165B2 (en)	2017-09-08	2025-07-17	Access To Advanced Health Institute	Liposomal formulations comprising saponin and methods of use
US12318436B2 (en)	2019-05-25	2025-06-03	Access To Advanced Health Institute	Composition and method for spray drying an adjuvant vaccine emulsion
WO2022051022A1 (en)	2020-09-04	2022-03-10	Infectious Disease Research Institute	Co-lyophilized rna and nanostructured lipid carrier
WO2024052882A1 (en)	2022-09-09	2024-03-14	Access To Advanced Health Institute	Immunogenic vaccine composition incorporating a saponin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57106626A (en) *	1980-12-22	1982-07-02	Teijin Ltd	Cytotoxic protein complex and its preparation
US4455296A (en) *	1982-02-02	1984-06-19	Board Of Regents, The University Of Texas System	Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae
US4671958A (en) *	1982-03-09	1987-06-09	Cytogen Corporation	Antibody conjugates for the delivery of compounds to target sites
FR2524487B1 (fr) *	1982-04-05	1985-11-22	Pasteur Institut	Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants
US4596674A (en) *	1984-09-11	1986-06-24	Merck & Co., Inc.	Immunogenic HAV peptides
DE3625257A1 (de) *	1986-07-23	1988-02-04	Behringwerke Ag	Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
NZ223009A (en) *	1986-12-31	1990-06-26	Nl Rivm Of Thoven	Oligosaccharides containing d-ribose d-ribitol and phosphate units mimicing haemophilus influenzae type b antigens
EP0320942A3 (en) *	1987-12-18	1989-10-04	American Cyanamid Company	Novel polysaccharides novel macromolecular conjugates of the polysaccharides
PT97073A (pt) *	1990-03-20	1991-10-31	Behringwerke Ag	Processo para a preparacao de epitopos soro-reactivos de proteinas de papillomavirus 16 humano (hpv)
EP1471147A3 (en) *	1991-07-19	2007-03-21	The University Of Queensland	Method of making a recombinant molecule for the expression of HPV-16 L1 protein

1993
- 1993-06-24 DE DE122007000100C patent/DE122007000100I1/de active Pending
- 1993-06-24 DE DE122007000095C patent/DE122007000095I1/de active Pending
- 1993-06-24 ES ES93916789T patent/ES2294778T3/es not_active Expired - Lifetime
- 1993-06-24 AT AT93916789T patent/ATE380871T1/de active
- 1993-06-24 WO PCT/US1993/006109 patent/WO1994000152A1/en not_active Ceased
- 1993-06-24 DE DE122007000096C patent/DE122007000096I1/de active Pending
- 1993-06-24 DE DE122007000097C patent/DE122007000097I1/de active Pending
- 1993-06-24 DE DE69334192T patent/DE69334192T2/de not_active Expired - Lifetime
- 1993-06-24 PT PT93916789T patent/PT647140E/pt unknown
- 1993-06-24 DE DE122007000098C patent/DE122007000098I1/de active Pending
- 1993-06-24 DE DE122007000099C patent/DE122007000099I1/de active Pending
- 1993-06-24 DK DK93916789T patent/DK0647140T3/da active
- 1993-06-24 DE DE122007000101C patent/DE122007000101I1/de active Pending
- 1993-06-24 EP EP07013259A patent/EP1835029A1/en not_active Withdrawn
- 1993-06-24 DE DE122007000094C patent/DE122007000094I1/de active Pending
- 1993-06-24 EP EP93916789A patent/EP0647140B1/en not_active Expired - Lifetime
1995
- 1995-01-24 AU AU11352/95A patent/AU697743C/en not_active Expired
- 1995-06-07 US US08/473,228 patent/US20020068326A1/en not_active Abandoned
1996
- 1996-12-16 US US08/764,926 patent/US8012679B1/en not_active Expired - Fee Related
2005
- 2005-12-14 LU LU91395C patent/LU91395I2/fr unknown
2007
- 2007-12-14 LU LU91394C patent/LU91394I2/fr unknown
- 2007-12-14 LU LU91396C patent/LU91396I2/fr unknown
- 2007-12-14 LU LU91400C patent/LU91400I2/fr unknown
- 2007-12-14 NL NL300320C patent/NL300320I1/nl unknown
- 2007-12-14 LU LU91397C patent/LU91397I2/fr unknown
- 2007-12-14 NL NL300322C patent/NL300322I1/nl unknown
- 2007-12-14 NL NL300318C patent/NL300318I2/nl unknown
- 2007-12-14 NL NL300316C patent/NL300316I1/nl unknown
- 2007-12-14 NL NL300319C patent/NL300319I1/nl unknown
- 2007-12-14 NL NL300315C patent/NL300315I2/nl unknown
- 2007-12-14 LU LU91393C patent/LU91393I2/fr unknown
- 2007-12-14 LU LU91399C patent/LU91399I2/fr unknown
- 2007-12-14 LU LU91398C patent/LU91398I2/fr unknown
- 2007-12-14 NL NL300317C patent/NL300317I1/nl unknown
- 2007-12-14 NL NL300321C patent/NL300321I1/nl unknown
- 2007-12-21 FR FR07C0073C patent/FR07C0073I2/fr active Active

Also Published As

Publication number	Publication date
LU91397I2 (fr)	2008-02-14
EP0647140A4 (en)	1997-03-19
EP0647140B1 (en)	2007-12-12
WO1994000152A1 (en)	1994-01-06
LU91396I2 (fr)	2008-02-14
DE122007000096I1 (de)	2008-03-27
DE122007000094I1 (de)	2008-03-27
NL300320I1 (nl)	2008-03-03
LU91399I2 (fr)	2008-02-14
ATE380871T1 (de)	2007-12-15
FR07C0073I2 (fr)	2012-08-03
FR07C0073I1 (nl)	2008-01-02
LU91398I2 (fr)	2008-02-14
NL300319I1 (nl)	2008-03-03
AU697743B2 (en)	1998-10-15
NL300316I1 (nl)	2008-02-01
LU91394I2 (fr)	2008-02-14
DE122007000100I1 (de)	2008-03-27
NL300317I1 (nl)	2008-02-01
DE122007000097I1 (de)	2008-03-27
DE122007000101I1 (de)	2008-03-27
NL300322I1 (nl)	2008-03-03
AU697743C (en)	2007-06-14
LU91395I2 (fr)	2008-02-14
US20020068326A1 (en)	2002-06-06
DE69334192T2 (de)	2008-12-04
DE122007000095I1 (de)	2008-03-27
DE69334192D1 (de)	2008-01-24
NL300321I1 (nl)	2008-03-03
AU1135295A (en)	1996-02-08
EP0647140A1 (en)	1995-04-12
EP1835029A1 (en)	2007-09-19
LU91400I2 (fr)	2008-02-14
NL300315I2 (nl)	2008-03-03
DE122007000099I1 (de)	2008-03-27
LU91393I2 (fr)	2008-02-14
NL300318I1 (nl)	2008-02-01
DK0647140T3 (da)	2008-02-04
DE122007000098I1 (de)	2008-03-27
NL300318I2 (nl)	2008-03-03
US8012679B1 (en)	2011-09-06
ES2294778T3 (es)	2008-04-01
PT647140E (pt)	2007-12-27